Back
Integra LifeSciences Holdings Corp. 10K Form
Sell
26
IART
Integra LifeSciences Holdings Corp.
Last Price:
$13.58
Seasonality Move:
2.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-06 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
| 2023-10-25 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
| 2023-07-27 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
| 2023-04-26 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
| 2022-10-26 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
| 2022-07-27 | 10Q | IART/Integra LifeSciences Holdings Corp. Quarterly |
Receive IART News And Ratings
See the #1 stock for the next 7 days that we like better than IART
IART Financial Statistics
Sales & Book Value
| Annual Sales: | $1.6B |
|---|---|
| Cash Flow: | $25.8M |
| Price / Cash Flow: | 10.6 |
| Annual Sales: | $13.33 |
| Price / Book: | 1.02 |
Profitability
| EPS (TTM): | -6.46100 |
|---|---|
| Net Income (TTM): | $-495.3M |
| Gross Margin: | $898.8M |
| Return on Equity: | -37.15% |
| Return on Assets: | -12.72% |
Integra LifeSciences Holdings Corp. Earnings Forecast
Key Integra LifeSciences Holdings Corp. Financial Ratios
-
The Gross Profit Margin over the past 30 years for IART is 55.80%.
-
The Selling, General & Administrative Expenses for IART have been equal to 44.52% of Gross Profit Margin.
-
The Research & Development expenses have been 3.38% of Revenue.
-
The Net Earning history of IART is -0.43% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 15 years.
Integra LifeSciences Holdings Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | IART |
| CUSIP: | 457985 |
| Website: | integralife.com |
Debt
| Debt-to-Equity Ratio: | 1.93 |
|---|---|
| Current Ratio: | 3.14 |
| Quick Ratio: | 1.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.43 |
|---|---|
| Forward P/E Ratio: | 5.76 |
IART Technical Analysis vs Fundamental Analysis
Sell
26
Integra LifeSciences Holdings Corp. (IART)
is a Sell
Is Integra LifeSciences Holdings Corp. a Buy or a Sell?
-
Integra LifeSciences Holdings Corp. stock is rated a SellThe current Integra LifeSciences Holdings Corp. [IART] share price is $13.57. The Score for IART is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.